WHO announces 8th death from novel coronavirus

"A 69-year-old man in Saudi Arabia died after being infected with a new SARS-related virus, becoming the 14th confirmed case and the eighth death, the World Health Organization said" on Wednesday, Bloomberg reports. "Preliminary investigations indicated the patient had no contact with previously reported cases of infection with the novel coronavirus," the news agency writes (Bennet, 3/7). "The patient was a 69-year-old man who was hospitalized on February 10 and died on February 19," CIDRAP News notes, adding, "His illness raises the global number of infections from the new virus to 14, including eight deaths."

"The wide illness spectrum has left health officials wondering if current surveillance for NCoV is missing mild or asymptomatic infections and if new strategies are needed," the news service continues (Schnerring, 3/6). The WHO "has asked countries to be alert to unusual patterns of disease among patients who fall ill with respiratory infections, but has not recommended travel or trade restrictions on any of the countries involved," the Guardian reports (Sample, 3/7). The CDC "on Thursday warned state and local health officials about potential infections from" the coronavirus, Reuters/Chicago Tribune notes (3/7).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Phase 2 study evaluates safety and efficacy of asunercept in COVID-19 patients